Immatics (IMTX): Baker Bros. group reports 9.5M-share, 7% ownership stake
Baker Bros. Advisors LP and related reporting persons filed Amendment No. 6 reporting beneficial ownership of 9,508,565 ordinary shares of Immatics N.V. (IMTX), held via Baker Brothers Life Sciences, L.P. and 667, L.P. The stake equals 7.0% based on 136,673,161 shares outstanding as of March 31, 2026, per Immatics’ Form 6-K.
How this was made
The 30-second read
Why it matters
Disclosed beneficial ownership at 7.0% with sole voting and dispositive power can shift positioning and perceived influence, but the text provides no stated plans or operational changes by Immatics.
Market read
Traders may monitor for follow-on activist or strategic disclosures, but this specific update mainly informs ownership/control positioning.
What to watch
The filing details sole voting and dispositive power, but it does not state activist objectives, planned transactions, or changes to strategy; traders should wait for any follow-on 13D/8-K signals before trading aggressively.
Background
The article summarizes an SEC beneficial ownership amendment (Amendment No. 6) by Baker Bros. Advisors LP and related persons for Immatics N.V.
Ticker impact
Baker Bros. Advisors filed Amendment No. 6 reporting beneficial ownership of 9,508,565 Immatics ordinary shares, or 7.0% of the class.
Likely limited near-term impact unless traders connect the stake to a broader strategic move; expect modest sentiment/positioning effects only.
This is a Schedule 13G/A style disclosure of beneficial ownership and voting/dispositive power, not a transaction with disclosed intent, financing, or company action. Without additional context (e.g., activist plans, board changes), price reaction should be muted.
Market effects
Minimal, as the disclosure is company-specific ownership control information rather than a sector-wide regulatory or clinical development.
None indicated; no cross-border market mechanism described beyond the issuer’s N.V. structure.
Low; no global deal, partnership, or regulatory action tied to the stake is mentioned.
Counterpoint
A 13G/A stake can be passive and may not translate into any near-term corporate action, so the market may overreact to the headline ownership percentage.
Key entities
- issuerImmatics N.V.
Company whose ordinary shares are subject of the beneficial ownership disclosure.
- reporting_personBaker Bros. Advisors LP
Reporting entity disclosing beneficial ownership of 9,508,565 ordinary shares (7.0%).
- holderBaker Brothers Life Sciences, L.P.
Direct holder of the reported ordinary shares per the filing summary.
